Alex S. Siebner , Marrium Habib , Vanesa Osmani , Ayola Akim Adegnika , Christian Bogdan , Minka Breloer , Alison Elliott , Anahita Fathi , Greet Hendrickx , Justin Komguep Nono , Roland Lang , Johannes U. Mayer , Benjamin Mordmüller , Esther Ndungo , Ulrike Protzer , Maria Yazdanbakhsh , Stefanie J. Klug , Clarissa Prazeres da Costa , Meral Esen
{"title":"关于疫苗的挑战和机遇的跨学科研讨会:当前和未来疫苗战略的综合方法,以提高复杂慢性感染情况下疫苗的有效性","authors":"Alex S. Siebner , Marrium Habib , Vanesa Osmani , Ayola Akim Adegnika , Christian Bogdan , Minka Breloer , Alison Elliott , Anahita Fathi , Greet Hendrickx , Justin Komguep Nono , Roland Lang , Johannes U. Mayer , Benjamin Mordmüller , Esther Ndungo , Ulrike Protzer , Maria Yazdanbakhsh , Stefanie J. Klug , Clarissa Prazeres da Costa , Meral Esen","doi":"10.1016/j.jvacx.2025.100615","DOIUrl":null,"url":null,"abstract":"<div><div>Vaccination is a key public health intervention, but vaccine immunogenicity, efficacy, and effectiveness vary geographically. These variations are not yet fully understood but are likely influenced by factors such as chronic infections, environmental and genetic differences, social and behavioral factors, and operational challenges, particularly in low- and middle-income countries (LMICs). To address these issues, the “International Symposium on Global Challenges and Opportunities for Vaccines” was held in Kloster Bernried, Germany, bringing together international scientists and stakeholders. Key discussions included: (1) Compromised vaccine immunogenicity due to helminth infections, (2) new vaccine approaches in vaccine development, (3) new frontiers in therapeutic vaccination, (4) challenges of vaccine trials, especially in low-resource settings, and (5) conceptualizing vaccine confidence in low and high resource contexts. The symposium highlighted the challenges of conducting vaccine trials in LMICs, such as participant follow-up, logistics, resources, and building trust. The main recommendation was to improve future vaccine trial designs through a comprehensive, interdisciplinary approach, including tools to evaluate vaccine immunogenicity, efficacy, and effectiveness.</div></div>","PeriodicalId":43021,"journal":{"name":"Vaccine: X","volume":"23 ","pages":"Article 100615"},"PeriodicalIF":2.7000,"publicationDate":"2025-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Interdisciplinary symposium on challenges and opportunities for vaccines: A comprehensive approach of current and future vaccine strategies to improve vaccine effectiveness in complex chronic infectious contexts\",\"authors\":\"Alex S. Siebner , Marrium Habib , Vanesa Osmani , Ayola Akim Adegnika , Christian Bogdan , Minka Breloer , Alison Elliott , Anahita Fathi , Greet Hendrickx , Justin Komguep Nono , Roland Lang , Johannes U. Mayer , Benjamin Mordmüller , Esther Ndungo , Ulrike Protzer , Maria Yazdanbakhsh , Stefanie J. Klug , Clarissa Prazeres da Costa , Meral Esen\",\"doi\":\"10.1016/j.jvacx.2025.100615\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><div>Vaccination is a key public health intervention, but vaccine immunogenicity, efficacy, and effectiveness vary geographically. These variations are not yet fully understood but are likely influenced by factors such as chronic infections, environmental and genetic differences, social and behavioral factors, and operational challenges, particularly in low- and middle-income countries (LMICs). To address these issues, the “International Symposium on Global Challenges and Opportunities for Vaccines” was held in Kloster Bernried, Germany, bringing together international scientists and stakeholders. Key discussions included: (1) Compromised vaccine immunogenicity due to helminth infections, (2) new vaccine approaches in vaccine development, (3) new frontiers in therapeutic vaccination, (4) challenges of vaccine trials, especially in low-resource settings, and (5) conceptualizing vaccine confidence in low and high resource contexts. The symposium highlighted the challenges of conducting vaccine trials in LMICs, such as participant follow-up, logistics, resources, and building trust. The main recommendation was to improve future vaccine trial designs through a comprehensive, interdisciplinary approach, including tools to evaluate vaccine immunogenicity, efficacy, and effectiveness.</div></div>\",\"PeriodicalId\":43021,\"journal\":{\"name\":\"Vaccine: X\",\"volume\":\"23 \",\"pages\":\"Article 100615\"},\"PeriodicalIF\":2.7000,\"publicationDate\":\"2025-03-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Vaccine: X\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S2590136225000099\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q3\",\"JCRName\":\"IMMUNOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Vaccine: X","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2590136225000099","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"IMMUNOLOGY","Score":null,"Total":0}
Interdisciplinary symposium on challenges and opportunities for vaccines: A comprehensive approach of current and future vaccine strategies to improve vaccine effectiveness in complex chronic infectious contexts
Vaccination is a key public health intervention, but vaccine immunogenicity, efficacy, and effectiveness vary geographically. These variations are not yet fully understood but are likely influenced by factors such as chronic infections, environmental and genetic differences, social and behavioral factors, and operational challenges, particularly in low- and middle-income countries (LMICs). To address these issues, the “International Symposium on Global Challenges and Opportunities for Vaccines” was held in Kloster Bernried, Germany, bringing together international scientists and stakeholders. Key discussions included: (1) Compromised vaccine immunogenicity due to helminth infections, (2) new vaccine approaches in vaccine development, (3) new frontiers in therapeutic vaccination, (4) challenges of vaccine trials, especially in low-resource settings, and (5) conceptualizing vaccine confidence in low and high resource contexts. The symposium highlighted the challenges of conducting vaccine trials in LMICs, such as participant follow-up, logistics, resources, and building trust. The main recommendation was to improve future vaccine trial designs through a comprehensive, interdisciplinary approach, including tools to evaluate vaccine immunogenicity, efficacy, and effectiveness.